Decreased CDK10 expression correlates with lymph node metastasis and predicts poor outcome in breast cancer patients - a short report

[1] Torre LA(2015)Global cancer statistics, 2012 CA Cancer J. Clin. 65 87-108

[2] Bray F(2000)Molecular portraits of human breast tumours Nature 406 747-752

[3] Siegel RL(2010)Management of breast cancer with targeted agents: importance of heterogeneity Nat. Rev. Clin. Oncol. 7 139-147

[4] Ferlay J(2008)Molecular subtypes in breast cancer evaluation and management: divide and conquer Cancer Investig. 26 1-10

[5] Lortet-Tieulent J(2002)Gene expression profiling predicts clinical outcome of breast cancer Nature 415 530-536

[6] Jemal A(2012)Comprehensive molecular portraits of human breast tumours Nature 490 61-70

[7] Perou CM(2009)Biological determinants of endocrine resistance in breast cancer Nat. Rev. Cancer 9 631-643

[8] Sørlie T(2007)Trastuzumab-mechanism of action and use in clinical practice N. Engl. J. Med. 357 39-51

[9] Eisen MB(1995)Chromosomal mapping of members of the cdc2 family of protein kinases, cdk3, cdk6, PISSLRE, and PITALRE, and a cdk inhibitor, p27Kip1, to regions involved in human cancer Cancer Res. 55 1199-1205

[10] van de Rijn M(1999)The PISSLRE gene: structure, exon skipping, and exclusion as tumor suppressor in breast cancer Genomics 56 90-97

[1] Torre LA(2015)Global cancer statistics, 2012 CA Cancer J. Clin. 65 87-108

[2] Bray F(2000)Molecular portraits of human breast tumours Nature 406 747-752

[3] Siegel RL(2010)Management of breast cancer with targeted agents: importance of heterogeneity Nat. Rev. Clin. Oncol. 7 139-147

[4] Ferlay J(2008)Molecular subtypes in breast cancer evaluation and management: divide and conquer Cancer Investig. 26 1-10

[5] Lortet-Tieulent J(2002)Gene expression profiling predicts clinical outcome of breast cancer Nature 415 530-536

[6] Jemal A(2012)Comprehensive molecular portraits of human breast tumours Nature 490 61-70

[7] Perou CM(2009)Biological determinants of endocrine resistance in breast cancer Nat. Rev. Cancer 9 631-643

[8] Sørlie T(2007)Trastuzumab-mechanism of action and use in clinical practice N. Engl. J. Med. 357 39-51

[9] Eisen MB(1995)Chromosomal mapping of members of the cdc2 family of protein kinases, cdk3, cdk6, PISSLRE, and PITALRE, and a cdk inhibitor, p27Kip1, to regions involved in human cancer Cancer Res. 55 1199-1205

[10] van de Rijn M(1999)The PISSLRE gene: structure, exon skipping, and exclusion as tumor suppressor in breast cancer Genomics 56 90-97